We are designing a system that is able to keep the concentration of a drug near its target concentration in the blood (i.e., its therapeutic window). Our initial work focused on chemotherapies, where ...
Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...
A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: ...
A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire body in a Phase III trial.
Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...
This story was originally published by ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
Extension for Community Healthcare Outcomes-Palliative Care in Africa and Quality of Life, Symptoms, Patient Experience, and Caregiver Distress Among Patients With Cancer Among 100 enrolled patients, ...
Subcutaneous administration of the anti-PD-1 monoclonal antibody toripalimab achieves similar drug exposure as the intravenous formulation in advanced non-squamous non-small cell lung cancer (NSCLC), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results